Skip to content

Roivant Sciences ROIV Ratios & Valuation

Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24
Efficiency
Asset turnover0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio18.4×-12.3×30.7×-3.0×33.7×-6.8×40.5×+7.1×33.5×-4.4×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$6.52+6.5%$6.13-4.4%$6.41+0.3%$6.39-1.1%$6.46-10.0%
Valuation
Market capitalization$19.82B+31.4%$15.09B+46.1%$10.33B+31.7%$7.84B+9.0%$7.2B-16.4%
Price / sales2,400.1×+1,266×1,133.9×+626×508.2×+171×337.7×+89.9×247.8×-34.5×
Price / book4.4×+0.8×3.5×+1.2×2.4×+0.6×1.8×+0.3×1.5×-0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Roivant Sciences's ratios come from?
Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.